Skip to content

SCHEDULE 13D/AAccepted Sep 18, 5:32 PM ET

Rapport Therapeutics, Inc. SCHEDULE 13D/A

Sofinnova Venture Partners XI, L.P.

Accepted (ET)

5:32 PM

Sep 18, 2025

Filed

Sep 18, 2025

Documents

3

Size

63.2 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.